The store will not work correctly when cookies are disabled.
2,6-Difluoro-3-{3-[3-(trifluoromethyl)phenyl]propoxy}benzamide
ID: ALA5085966
PubChem CID: 166636292
Max Phase: Preclinical
Molecular Formula: C17H14F5NO2
Molecular Weight: 359.29
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1c(F)ccc(OCCCc2cccc(C(F)(F)F)c2)c1F
Standard InChI: InChI=1S/C17H14F5NO2/c18-12-6-7-13(15(19)14(12)16(23)24)25-8-2-4-10-3-1-5-11(9-10)17(20,21)22/h1,3,5-7,9H,2,4,8H2,(H2,23,24)
Standard InChI Key: LEHJEUGFXWKVLT-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
8.3409 -16.3086 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.7536 -17.0185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1620 -16.3061 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.6424 -17.4421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6390 -18.2577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3465 -18.6651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0546 -18.2554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0507 -17.4339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3426 -17.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4661 -17.4267 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.6866 -16.2200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6855 -17.0395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3935 -17.4485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1032 -17.0390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1004 -16.2164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -15.8111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3893 -14.9939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0958 -14.5832 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6804 -14.5874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8115 -17.4465 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5186 -17.0368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8065 -15.8051 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.9788 -15.8115 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.2269 -17.4443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9340 -17.0346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 2 1 0
2 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
16 17 1 0
17 18 1 0
17 19 2 0
14 20 1 0
20 21 1 0
15 22 1 0
11 23 1 0
21 24 1 0
24 25 1 0
25 4 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.29 | Molecular Weight (Monoisotopic): 359.0945 | AlogP: 4.09 | #Rotatable Bonds: 6 |
Polar Surface Area: 52.32 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.97 | CX Basic pKa: ┄ | CX LogP: 4.29 | CX LogD: 4.29 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.62 | Np Likeness Score: -1.23 |
References
1. Huecas S, Araújo-Bazán L, Ruiz FM, Ruiz-Ávila LB, Martínez RF, Escobar-Peña A, Artola M, Vázquez-Villa H, Martín-Fontecha M, Fernández-Tornero C, López-Rodríguez ML, Andreu JM.. (2021) Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery., 64 (9.0): [PMID:33908781] [10.1021/acs.jmedchem.0c02207] |